Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04434040 |
|---|---|
| Brief Title: | Atezolizumab + Sacituzumab Govitecan to Prevent Recurrence in TNBC (ASPRIA) |
| First Submitted : | June 14, 2020 |
| First Submitted that Met QC Criteria : | June 14, 2020 |
| First Posted : | June 16, 2020 |
| Last Update Submitted that Met QC Criteria : | May 25, 2022 |
| Last Update Posted : | May 27, 2022 |